{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:33:14Z","timestamp":1782401594423,"version":"3.54.5"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Epidemiological characteristics of nonalcoholic fatty liver disease (NAFLD) in Chongqing, a west-central city of China, remain unclear. The objective of this study was to investigate the prevalence of NAFLD and the related risk factors among healthy adults for physical examination in Chongqing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 110,626 subjects were enrolled in the present study. Each of the participants underwent physical examination, laboratory measurements, and abdominal ultrasonography. The chi-square test was employed to compare differences in the NAFLD prevalence, and logistic regression analysis was used to estimate the odds ratio for risk factors of NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of NAFLD in individuals in the population of Chongqing was 28.5%, and the prevalence in men (38.1%) was significantly higher than that in women (13.6%) (OR = 2.44; 95% CI: 2.31\u20132.58). NAFLD was more common in men aged 51\u201360 years and women over 60 years. Approximately 79.1% of the people with obesity and 52.1% of the people with central obesity had NAFLD. The prevalence of NAFLD in people with hypertension and cholelithiasis was 48.9 and 38.4%, respectively. Logistic regression showed that gender, age, body max index (BMI), central obesity, hypertension, impaired fasting glucose\/diabetes mellitus (DM), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), hyperuricemia (HUA), alanine transaminase (ALT), and cholelithiasis were independently associated with the presence of NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The prevalence of NAFLD among healthy adults in Chongqing was high. To improve the prevention and management of NAFLD, special attention should be paid to the factors associated with the presence of NAFLD, including higher BMI, higher waist circumference, higher blood glucose, hypertension, hypertriglyceridemia, hyperuricemia, cholelithiasis, and elevated ALT.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1127489","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T15:23:21Z","timestamp":1680189801000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: A cross-sectional study in Chongqing, China"],"prefix":"10.3389","volume":"11","author":[{"given":"Lingxi","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/MEG.0000000000001235","article-title":"Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies","volume":"30","author":"Tomic","year":"2018","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gtc.2019.09.007","article-title":"Burden of disease due to nonalcoholic fatty liver disease","volume":"49","author":"Muthiah","year":"2020","journal-title":"Gastroenterol Clin North Am."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steato-hepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1478-3231.2007.01483.x","article-title":"Current concepts in the pathogenesis of nonalcoholic fatty liver disease","volume":"27","author":"M\u00e9ndez-S\u00e1nchez","year":"2007","journal-title":"Liver Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","article-title":"Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"20","author":"Orci","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s12072-013-9480-x","article-title":"Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)","volume":"7","author":"Duseja","year":"2013","journal-title":"Hepatol Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1751-2980.2008.00331.x","article-title":"Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases","volume":"9","author":"Zeng","year":"2008","journal-title":"J Dig Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3969\/j.issn.1001-5256.2010.06.029","article-title":"Prevalence of cholelithiasis and associated risk factors among adult population in Shanghai","volume":"26","author":"Zhu","year":"2010","journal-title":"J Clin Hepatol."},{"key":"B14","first-page":"1","article-title":"The guidelines for prevention and control of overweight and obesity in Chinese adults","volume":"17","author":"Chen","year":"2004","journal-title":"Biomed Environ Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0895-3988(10)60025-6","article-title":"Characteristics of obesity and its related disorders in China","volume":"23","author":"Jia","year":"2010","journal-title":"Biomed Environ Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3760\/cma.j.issn.0253-3758.2011.07.002","article-title":"2010 Chinese guidelines for the management of hypertension","volume":"39","author":"Liu","year":"2011","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"B17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3760\/cma.j.issn.0253-3758.2016.10.005","article-title":"2016 Chinese guideline for the management of dyslipidemia in adults","volume":"44","year":"2016","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"B19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/hep.21248","article-title":"Statins and hepatic steatosis: perspectives from the Dallas Heart Study","volume":"44","author":"Browning","year":"2006","journal-title":"Hepatology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0171502","DOI":"10.1371\/journal.pone.0171502","article-title":"Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: a large Dutch population cohort","volume":"12","author":"van den Berg","year":"2017","journal-title":"PLoS ONE."},{"key":"B21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4415\/ANN_17_01_14","article-title":"Association of non-alcoholic fatty liver disease and cardiometabolic risk factors with early atherosclerosis in an adult population in Southern Italy","volume":"53","author":"Caserta","year":"2017","journal-title":"Ann Ist Super Sanita."},{"key":"B22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/hep.25593","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification","volume":"56","author":"Kim","year":"2012","journal-title":"Hepatology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","author":"Hamaguchi","year":"2005","journal-title":"Ann Intern Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/DMSO.S80364","article-title":"Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study","volume":"8","author":"Lesmana","year":"2015","journal-title":"Diabetes Metab Syndr Obes."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological Features of NAFLD From 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","article-title":"Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography","volume":"61","author":"Wong","year":"2012","journal-title":"Gut."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0021","DOI":"10.1097\/MD.0000000000010021","article-title":"Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China","volume":"97","author":"Lin","year":"2018","journal-title":"Medicine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","article-title":"Prevalence of and risk factors for fatty liver in a general population of Shanghai, China","volume":"43","author":"Fan","year":"2005","journal-title":"J Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-230X-12-123","article-title":"Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units","volume":"12","author":"Hu","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/hep.20463","article-title":"Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure","volume":"40","author":"Di Martino","year":"2004","journal-title":"Hepatology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0378-5122(03)00246-9","article-title":"Serum lipids in oophorectomized women during estrogen and testosterone replacement therapy","volume":"47","author":"Fl\u00f6ter","year":"2004","journal-title":"Maturitas."},{"key":"B32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/gme.0b013e3181974ffc","article-title":"Androgens, estrogens, and metabolic syndrome at midlife","volume":"16","author":"Shifren","year":"2009","journal-title":"Menopause."},{"key":"B33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults","volume":"21","author":"Park","year":"2006","journal-title":"J Gastroenterol Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study","volume":"47","author":"Eguchi","year":"2012","journal-title":"J Gastroenterol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e3156","DOI":"10.1002\/dmrr.3156","article-title":"Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort","volume":"35","author":"Zhou","year":"2019","journal-title":"Diabetes Metab Res Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.maturitas.2012.09.008","article-title":"Factors associated with the age of natural menopause and menopausal symptoms in Chinese women","volume":"73","author":"Li","year":"2012","journal-title":"Maturitas."},{"key":"B37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jhep.2008.10.010","article-title":"Epidemiology of non-alcoholic fatty liver disease in China","volume":"50","author":"Fan","year":"2009","journal-title":"J Hepatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e11293","DOI":"10.1097\/MD.0000000000011293","article-title":"Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China","volume":"97","author":"Weng","year":"2018","journal-title":"Medicine."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/j.1440-1746.2006.04781.x","article-title":"Effects of nonalcoholic fatty liver disease on the development of metabolic disorders","volume":"22","author":"Fan","year":"2007","journal-title":"J Gastroenterol Hepatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/HJH.0000000000000532","article-title":"Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk","volume":"33","author":"Aneni","year":"2015","journal-title":"J Hypertens."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/MEG.0b013e32834b8d52","article-title":"Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase","volume":"23","author":"L\u00f3pez-Su\u00e1rez","year":"2011","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/jhh.2010.72","article-title":"Insulin resistance in young, lean male subjects with essential hypertension","volume":"25","author":"Penesova","year":"2011","journal-title":"J Hum Hypertens."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","article-title":"AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions","volume":"49","year":"2017","journal-title":"Dig Liver Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/ajg.2013.104","article-title":"Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study","volume":"108","author":"Xu","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/ijms17040548","article-title":"Role of serum uric acid and ferritin in the development and progression of NAFLD","volume":"17","author":"Lombardi","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.4238\/2014.August.7.3","article-title":"Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes","volume":"13","author":"Bi","year":"2014","journal-title":"Genet Mol Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1445-5994.2009.01979.x","article-title":"Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes","volume":"40","author":"Hwang","year":"2010","journal-title":"Intern Med J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/00365521.2011.643481","article-title":"Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors","volume":"47","author":"Koller","year":"2012","journal-title":"Scand J Gastroenterol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e41183","DOI":"10.1371\/journal.pone.0041183","article-title":"Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease","volume":"7","author":"Fracanzani","year":"2012","journal-title":"PLoS ONE."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.3390\/biomedicines9121893","article-title":"Diet and gut microbiota interaction-derived metabolites and intrahepatic immune response in NAFLD development and treatment","volume":"9","author":"Yang","year":"2021","journal-title":"Biomedicines."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1127489\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T14:56:34Z","timestamp":1680533794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1127489\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":53,"alternative-id":["10.3389\/fpubh.2023.1127489"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1127489","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"article-number":"1127489"}}